As of Nov 25
| +0.06 / +1.89%|
The 8 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +332.10% increase from the last price of 3.24.
The current consensus among 8 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.